Literature DB >> 10634519

Telomerase activity in ductal carcinoma in situ of the breast.

B Shpitz1, S Zimlichman, R Zemer, Y Bomstein, T Zehavi, S Liverant, J Bernehim, Z Kaufman, E Klein, Y Shapira, A Klein.   

Abstract

Telomerase plays an important role in maintaining the stability of the chromosomes. Activity of telomerase has been detected in proliferating and immortalized cell lines and in a number of malignant tumors including invasive breast cancer. The aim of the study was to examine telomerase activity in ductal carcinoma in situ (DCIS), which is considered to be a precursor lesion of infiltrating breast carcinoma, using a PCR-based telomerase activity protocol (TRAP). We examined 35 samples obtained from histologically confirmed breast biopsies, including 13 normal breast tissues, 11 infiltrating ductal carcinoma (IDC), nine DCIS, and two DCIS with microinvasion. Telomerase activity was demonstrated in 8/9 samples of DCIS, both samples of DCIS with microinvasion, and all but one sample of IDC. Normal breast tissue had no demonstrable telomerase activity. Our results indicate that telomerase is activated frequently in early breast carcinogenesis, although its utilization as a biomarker in DCIS is questionable.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10634519     DOI: 10.1023/a:1006394209922

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  12 in total

Review 1.  Early breast cancer.

Authors:  Tomoyoshi Suzuki; Masakazu Toi; Shigehira Saji; Kazumi Horiguchi; Tomoyuki Aruga; Eiji Suzuki; Shinichiro Horiguchi; Nobuaki Funata; Katsuyuki Karasawa; Noriko Kamata
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

2.  Telomere loss provokes multiple pathways to apoptosis and produces genomic instability in Drosophila melanogaster.

Authors:  Simon W A Titen; Kent G Golic
Journal:  Genetics       Date:  2008-10-09       Impact factor: 4.562

3.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

Review 4.  Telomeres and telomerase in cancer.

Authors:  Steven E Artandi; Ronald A DePinho
Journal:  Carcinogenesis       Date:  2009-11-03       Impact factor: 4.944

5.  Constitutive telomerase expression promotes mammary carcinomas in aging mice.

Authors:  Steven E Artandi; Scott Alson; Maja K Tietze; Norman E Sharpless; Siqin Ye; Roger A Greenberg; Diego H Castrillon; James W Horner; Sarah R Weiler; Ruben D Carrasco; Ronald A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 6.  Culture models of human mammary epithelial cell transformation.

Authors:  M R Stampfer; P Yaswen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

7.  Telomerase activity, estrogen receptors (alpha, beta), Bcl-2 expression in human breast cancer and treatment response.

Authors:  Blanca Murillo-Ortiz; Horacio Astudillo-De la Vega; Sebastian Castillo-Medina; J M Malacara; Luis Benitez-Bribiesca
Journal:  BMC Cancer       Date:  2006-08-15       Impact factor: 4.430

8.  Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cells.

Authors:  Jonathan K Lee; James C Garbe; Lukas Vrba; Masaru Miyano; Bernard W Futscher; Martha R Stampfer; Mark A LaBarge
Journal:  Front Cell Dev Biol       Date:  2015-03-11

Review 9.  Telomerase: The Devil Inside.

Authors:  Mukesh Kumar; Andre Lechel; Çagatay Güneş
Journal:  Genes (Basel)       Date:  2016-07-29       Impact factor: 4.096

10.  Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes.

Authors:  Lukas Vrba; Bernard Walter Futscher
Journal:  J Breast Cancer       Date:  2017-06-26       Impact factor: 3.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.